Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 11.18%424.07B | 20.09%1.65T | 8.79%402.53B | 10.69%428.43B | 25.70%439.5B | 41.85%381.44B | 101.49%1.38T | 100.83%370B | 86.24%387.07B | 121.82%349.63B |
Cost of revenue | 13.16%219.56B | 8.66%840.85B | 10.04%218.87B | 10.79%218.97B | 6.98%208.99B | 6.63%194.02B | 35.77%773.86B | 31.22%198.91B | 34.18%197.65B | 39.16%195.35B |
Gross profit | 9.12%204.51B | 34.79%811.04B | 7.34%183.66B | 10.58%209.45B | 49.41%230.51B | 115.59%187.42B | 433.70%601.73B | 424.03%171.09B | 212.93%189.42B | 794.84%154.28B |
Operating expense | 18.10%184.9B | 24.87%670.11B | 20.51%168.68B | 13.56%171.89B | 35.00%172.98B | 33.59%156.57B | 54.43%536.67B | 49.11%139.97B | 63.85%151.36B | 56.07%128.13B |
Other operating expenses | 17.34%186.64B | 22.88%701.44B | 24.47%193.74B | 12.22%174.02B | 25.69%174.62B | 31.28%159.06B | 54.17%570.82B | 54.56%155.66B | 58.73%155.07B | 59.49%138.93B |
Total other operating income | -30.34%1.74B | -8.28%31.33B | 59.83%25.06B | -42.70%2.13B | -84.78%1.64B | -37.03%2.5B | 50.17%34.16B | 129.40%15.68B | -30.25%3.71B | 115.50%10.8B |
Operating profit | -36.44%19.61B | 116.62%140.93B | -51.86%14.98B | -1.31%37.56B | 120.03%57.53B | 201.94%30.86B | 127.71%65.06B | 150.83%31.12B | 219.54%38.06B | 140.31%26.15B |
Net non-operating interest income (expenses) | -279.22%-923M | 51.14%-5.93B | 55.83%-921M | 58.03%-2.87B | -37.62%-2.66B | 140.02%515M | -70.46%-12.14B | -18.80%-2.09B | -149.74%-6.83B | -39.05%-1.93B |
Non-operating interest income | -36.09%3B | 347.30%9.28B | 123.01%2.72B | 274.22%842M | -32.27%1.02B | 70.53%4.69B | 4.43%2.07B | -21.83%1.22B | -52.83%225M | 7,085.71%1.51B |
Non-operating interest expense | -6.09%3.92B | 7.02%15.21B | 10.22%3.64B | -47.44%3.71B | 6.95%3.68B | 3.39%4.17B | 56.06%14.21B | -0.33%3.31B | 119.67%7.06B | 144.07%3.44B |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 20.88%3.05B | 34.11%3.83B | 131.06%269M | 129.35%253M | -64.85%786M | 7.31%2.52B | -44.72%2.86B | -113.72%-866M | -276.64%-862M | 159.40%2.24B |
Income from associates and other participating interests | 73.13%-536M | 113.99%469M | 350.62%1.01B | 97.27%-74M | 374.24%1.53B | -737.38%-2B | 66.13%-3.35B | 68.12%-401M | -1,634.62%-2.71B | 89.20%-559M |
Special income (charges) | ||||||||||
Other non-operating income (expenses) | ||||||||||
Income before tax | -33.54%21.2B | 165.70%139.31B | -44.76%15.34B | 26.08%34.88B | 120.90%57.2B | 210.41%31.9B | 121.26%52.43B | 147.93%27.76B | 180.77%27.66B | 136.70%25.89B |
Income tax | -22.60%7.39B | 133.89%43.39B | -38.63%6.08B | 18.93%10.36B | 106.36%17.4B | 212.35%9.55B | 128.42%18.55B | 244.24%9.91B | 183.80%8.71B | 137.81%8.43B |
Net income | -38.21%13.81B | 183.12%95.91B | -48.17%9.25B | 29.37%24.51B | 127.93%39.8B | 209.60%22.35B | 118.68%33.88B | 134.97%17.86B | 179.45%18.95B | 136.18%17.46B |
Net income continuous operations | -38.21%13.81B | 183.12%95.91B | -48.17%9.25B | 29.37%24.51B | 127.93%39.8B | 209.60%22.35B | 118.68%33.88B | 134.97%17.86B | 179.45%18.95B | 136.18%17.46B |
Noncontrolling interests | 75.42%-176M | 168.92%377M | -58.98%-407M | -34.73%312M | 3,294.29%1.19B | 11.06%-716M | 85.58%-547M | 85.98%-256M | 195.03%478M | 102.91%35M |
Net income attributable to the company | -39.37%13.98B | 177.53%95.53B | -46.66%9.66B | 31.03%24.2B | 121.57%38.61B | 217.77%23.06B | 119.39%34.42B | 136.79%18.11B | 179.12%18.47B | 137.03%17.43B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0.00%-1M | 0 | -200.00%-1M | 1M | 0 | -1M | 0 | 200.00%1M | 0 | 0 |
Net income attributable to common stockholders | -39.37%13.98B | 177.53%95.53B | -46.65%9.66B | 31.02%24.2B | 121.57%38.61B | 217.77%23.06B | 119.39%34.42B | 136.79%18.11B | 179.12%18.47B | 137.03%17.43B |
Gross dividend payment | ||||||||||
Basic earnings per share | -39.36%32 | 177.53%218.61 | -46.65%22.11 | 31.01%55.38 | 121.60%88.35 | 217.76%52.77 | 119.39%78.77 | 136.79%41.44 | 179.13%42.27 | 137.03%39.87 |
Diluted earnings per share | -39.36%32 | 177.53%218.61 | -46.65%22.1095 | 31.01%55.38 | 121.60%88.35 | 217.76%52.77 | 119.39%78.77 | 136.79%41.44 | 179.13%42.27 | 137.03%39.87 |
Dividend per share | 0 | 200.00%75 | 80.00%45 | 0 | 30 | 0 | 25 | 25 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |